Dr. Solmaz Sahebjam

Solmaz Sahebjam, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Neuro-Oncology Branch


Dr. Sahebjam is a medical oncologist and neuro-oncologist at the Neuro-Oncology Branch (NOB), interested in developing new treatment strategies for cancer patients—specifically for those with primary and metastatic central nervous system tumors. 

Explore the NOB's Research Programs >

Areas of Expertise

1) Neuro-oncology 2) New drug development 3) Primary brain tumors 4) Immunotherapy 5) Precision therapy 6) Early phase clinical trials

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Key Publications

Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study

Solmaz Sahebjam, Peter A Forsyth, Nam D Tran, John A Arrington, Robert Macaulay, Arnold B Etame, Christine M Walko, Theresa Boyle, Edwin N Peguero, Michael Jaglal, Sepideh Mokhtari, Heiko Enderling, Natarajan Raghunand, Tyra Gatewood, Wendy Long, Jennifer L Dzierzeski, Brittany Evernden, Timothy Robinson, Melissa C Wicklund, Sungjune Kim, Zachary J Thompson, Dung-Tsa Chen, Prakash Chinnaiyan, Hsiang-Hsuan Michael Yu
Neuo-Oncology. 23(4): 677-686, 2021.
Full-Text Article
[ Journal Article ]

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer

Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras, Nancy U Lin, Melissa Bear, Sonya C Chapman, Zhengyu Yang, Yanyun Chen, Carey K Anders
Clinical Cancer Research. 26(20): 5310-5319, 2020.
Full-Text Article
[ Journal Article ]

Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements

Sarah C Brüningk, Jeffrey Peacock, Christopher J Whelan, Renee Brady-Nicholls, Hsiang-Hsuan M Yu, Solmaz Sahebjam, Heiko Enderling
Scientific Report. 11(1): 20219, 2021.
Full-Text Article
[ Journal Article ]

Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study

Nancy U Lin, Mark Pegram, Solmaz Sahebjam, Nuhad Ibrahim, Anita Fung, Anna Cheng, Alan Nicholas, Whitney Kirschbrown, Priya Kumthekar
Journal of Clinical Oncology. 39(24): 2667-2675, 2021.
Full-Text Article
[ Journal Article ]

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial

David A Reardon, Alba A Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim Baehring, Manmeet S Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepulveda, Paul De Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John Sampson, Michael Weller
JAMA Oncology. 6(7): 1003-1010, 2020.
Full-Text Article
[ Journal Article ]